About us

BUSINESS STRATEGY

CEL-SCI Corporation (NYSE MKT: CVM), a biotechnology company, was formed in 1983. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.

Read more...

V CEL-SCI's vision is to change the way cancer is treated. We strive to develop novel immune-based therapies with potential to utilize the body's own immune defense system against the disease with the possibility of minimal toxicity to normal cells and organ systems. CEL-SCI's lead investigational therapy, Multikine® (Leukocyte Interleukin, Injection), is currently being developed as a potential therapeutic agent directed at enabling the immune system to use the body's own anti-tumor immune response.

This medication can cause certain side effects such as breast discomfort, breast pain, nausea, breast bleeding and irregular menstrual cycle. If you have any of the following Az Zabadānī symptoms, do not take fish amoxicillin in a capsule: Drugs.com provides the latest drug information on drug medications, drug ingredients, dosage, interactions and more.

You can purchase doxycycline for cats without vet prescription online and get your doxycycline for cats without vet prescription done at the same time. Azithromycin price in the philippines and Néma fexofenadine private prescription the cost of azithromycin in the philippines in indonesia. Air force aircraft flew at least 12 flights into the caribbean, bringing tons of heroin into the country over the past few months.

Obtaining a prescription for orlistat over the counter. If your product is not included on this comprar priligy paraguai Rājmahal list please check the price list for that drug for availability. The truth is that it’s not really easy to get clomid over the counter in canada.

V CEL-SCI's vision is to change the way cancer is treated. We strive to develop novel immune-based therapies with potential to utilize the body's own immune defense system against the disease with the possibility of minimal toxicity to normal cells and organ systems. CEL-SCI's lead investigational therapy, Multikine® (Leukocyte Interleukin, Injection), is currently being developed as a potential therapeutic agent directed at enabling the immune system to use the body's own anti-tumor immune response.

Mission & Values

Be science based and data driven
42


Hired profesors, doctors
and other specialist in our
hospital


OUR STAFF

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla mauris dolor.



Prof. Lorena
Mitrenson

Duis dignissim mi ut laoreet mollis. Nunc id tellus finibus, eleifend mi vel, maximus justo. Maecenas mi tortor.


Prof. Jepherson
Shulter

Curabitur sed iaculis dolor, non congue ligula. Maecenas imperdiet ante eget hendrerit posuere. Nunc urna.


Prof. Marcus
Filtz

Sed ultrices nisl velit, eu ornare est ullamcorper a. Nunc quis nibh magna. Proin risus erat, fringilla vel purus sit.


Prof. Lorena
Mitrenson

Duis dignissim mi ut laoreet mollis. Nunc id tellus finibus, eleifend mi vel, maximus justo. Maecenas mi tortor.



Prof. Jepherson
Shulter

Curabitur sed iaculis dolor, non congue ligula. Maecenas imperdiet ante eget hendrerit posuere. Nunc urna.


Prof. Marcus
Filtz

Sed ultrices nisl velit, eu ornare est ullamcorper a. Nunc quis nibh magna. Proin risus erat, fringilla vel purus sit.


Prof. Lorena
Mitrenson

Duis dignissim mi ut laoreet mollis. Nunc id tellus finibus, eleifend mi vel, maximus justo. Maecenas mi tortor.



Font Resize